Crossmark

An open-label proof-of-concept study of intrathecal autologous bone marrow mononuclear cell transplantation in intellectual disability

Crossref DOI link: https://doi.org/10.1186/s13287-017-0748-2

Published Online: 2018-01-31

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sharma, Alok

Sane, Hemangi

Gokulchandran, Nandini

Pai, Suhasini https://orcid.org/0000-0003-3888-5425
Kulkarni, Pooja

Ganwir, Vaishali

Maheshwari, Maitree

Sharma, Ridhima

Raichur, Meenakshi

Nivins, Samson

Badhe, Prerna
More Information

Article History

Received: 12 June 2017

Revised: 21 November 2017

Accepted: 13 December 2017

First Online: 31 January 2018

Ethics approval and consent to participate

: The Institutional Committee for Stem Cell Research and Therapy (IC-SCRT) reviewed and approved the protocol of the study. The intervention was explained to the parents in detail along with possible adverse events. Written informed consent was obtained from the parents of the patients. The consent was also video recorded.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.